ALK-Abelló A/S ALK-Abelló A/S

ALK-Abelló A/S

ALK-B

Rank in Stocks #2348
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Share Price
$37.79
Market Cap
$8.38B
Change (1 day)
4.29%
Change (1 year)
16.81%
Country
DK
Trade ALK-Abelló A/S (ALK-B)

Category

Healthcare
Stock split history for ALK-Abelló A/S (ALK-B)
ALK-Abelló A/S stock (symbol: ALK-B) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 19, 2026.
One ALK-B share bought prior to Oct 19, 2026 would equal to 0 ALK-B shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL